| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized, placebo-controlled, single ascending-dose study to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tralokinumab in Japanese healthy volunteers
|
Baverel, Paul
|
|
2018
|
33 |
3 |
p. 150-158
|
artikel
|
| 2 |
Assessment of induced CYP3A activity in pregnant women using 4β-hydroxycholesterol: Cholesterol ratio as an appropriate metabolic marker
|
Kim, Andrew HyoungJin
|
|
2018
|
33 |
3 |
p. 173-178
|
artikel
|
| 3 |
Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese population
|
Hiratsuka, Masahiro
|
|
2018
|
33 |
3 |
p. 141-149
|
artikel
|
| 4 |
Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes
|
Lee, Eunyoung
|
|
2018
|
33 |
3 |
p. 159-163
|
artikel
|
| 5 |
Total hepatocellular disposition profiling of rosuvastatin and pitavastatin in sandwich-cultured human hepatocytes
|
Kanda, Katsuhiro
|
|
2018
|
33 |
3 |
p. 164-172
|
artikel
|
Tijdschrift beschrijving